📰 Veronica Eames News
Veronica Eames News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Veronica Eames. Real-time updates on events, politics, business and more.
April 22, 2024
SAN DIEGO, April 22, 2024 -- Cidara Therapeutics, Inc. , a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate immunotherapies designed to save lives...
April 22, 2024
SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary...
April 22, 2024
SAN DIEGO, April 22, 2024 -- Cidara Therapeutics, Inc. , a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate immunotherapies designed to save lives...
April 22, 2024
22.04.2024 - SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) - Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and ...
April 5, 2024
AU ZH, Switzerland, April 05, 2024 (GLOBE NEWSWIRE) -- Araris Biotech AG ("Araris" or "the Company"), a company pioneering a proprietary antibody-drug conjugate (ADC)- technology, today announced the company will
January 29, 2024
The UK MHRA approval follows approvals by the U.S. FDA and the European CommissionCidara is entitled to receive a milestone payment of approximate...
December 22, 2023
Approval based on positive results from the pivotal ReSTORE Phase III clinical trial and supported by the STRIVE Phase II clinical trials and extensive nonclinical development program.REZZAYO...
November 20, 2023
20.11.2023 - SOUTH SAN FRANCISCO, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) - Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral ...
November 4, 2023
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs
November 3, 2023
SAN DIEGO, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today announced new preclinical data on its drug-Fc conjugate (DFC) candidate, CBO421, at the Society for Immunotherapy of Cancer (SITC)’s 38th Annual Meeting. The conference is taking plac...